Evidence map›Paper›PMID 38270583›Full record

ArticleeLife2024

Light-inducible protein degradation in

Nathan Tague, Cristian Coriano-Ortiz, Michael B Sheets, Mary J Dunlop

Open access · goldAbstract read
In one paragraph

Article in eLife, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Protein design accelerates the development and application of optogenetic tools.Computational and structural biotechnology journal · 2025
    Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Nathan TagueDepartment of Biomedical Engineering, Boston University, Boston, United States.ORCID https://orcid.org/0000-0002-8114-6700
Cristian Coriano-OrtizDepartment of Biomedical Engineering, Boston University, Boston, United States.
Michael B SheetsDepartment of Biomedical Engineering, Boston University, Boston, United States.
Mary J DunlopDepartment of Biomedical Engineering, Boston University, Boston, United States.ORCID https://orcid.org/0000-0002-9261-8216
Boston University · US

Funding

Feedback and Noise in a Multiple Antibiotic Resistance CircuitR01AI102922 · NIAID · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI Mary J. Dunlop · 2014 to 2026
$4.7M
Translational Research in BiomaterialsT32EB006359 · NIBIB · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI MARK W. GRINSTAFF, Michelle H Teplensky · 2009 to 2026
$4.2M
Synthetic Biology and Biotechnology (SB2) Predoctoral Training ProgramT32GM130546 · NIGMS · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI CHEN, CHRISTOPHER S, KHALIL, AHMAD SAMIR · 2019 to 2023
$1.0M
NIAID NIH HHS R01 AI102922NIBIB NIH HHS T32 EB006359NIGMS NIH HHS T32 GM130546NIH HHS R01AI102922NIH HHS T32 EB006359NIH HHS T32 GM130546
6 · The paper itself

Abstract

Molecular tools for optogenetic control allow for spatial and temporal regulation of cell behavior. In particular, light-controlled protein degradation is a valuable mechanism of regulation because it can be highly modular, used in tandem with other control mechanisms, and maintain functionality throughout growth phases. Here, we engineered LOVdeg, a tag that can be appended to a protein of interest for inducible degradation in

Indexed as

Escherichia coliEscherichia coli ProteinsATP-Binding Cassette, Sub-Family C ProteinsBlue LightMetabolic EngineeringOptogeneticsProteolysisAcrB protein, E coliATP-Binding Cassette, Sub-Family C ProteinsEscherichia coli Proteinscomputational biologyE. coliinfectious diseasemicrobiologyoptogeneticsprotein degradationprotein engineeringsynthetic biologysystems biology

Identifiers

PMID38270583
PMCPMC10945698
OpenAlexW4381278284

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.